Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles
نویسندگان
چکیده
منابع مشابه
Diaminopyridine Treatment of Neurological Disorders
The drug 3, 4 diaminopyridine (DAP) is a potassium channel blocker, closely related to 4-aminopyridine. Like 4-AP, DAP blocks the voltage-sensitive potassium channel. However, unlike 4-AP, DAP does not cross the blood brain barrier unless the barrier is broken. DAP therefore should be well suited for treating peripheral demyelination and have less central nervous system mediated side-effects. M...
متن کاملStem Cell Therapy in Pediatric Neurological Disorders
Pediatric neurological disorders including muscular dystrophy, cerebral palsy, and spinal cord injury are defined as a heterogenous group of diseases, of which some are known to be genetic. The two significant features represented for stem cells, leading to distinguish them from other cell types are addressed as below: they can renew themselves besides the ability to differentiate into cells wi...
متن کاملherbal medicines in the treatment of psychiatric and neurological disorders
objective: this review will indicate the quality of the evidence supporting the clinical effects of a number of commonly used types of herbal medicines for psychiatric and neurological disorders. method: we conducted a review of literature to understand the biochemical and evidential bases for the use of herbs in psychiatric and neurological disorders as follow: 1) alzheimer’s disease, 2) depre...
متن کاملMessenger RNA-based therapeutics for the treatment of apoptosis-associated diseases
Gene therapy is a promising approach for treating diseases that are closely associated with excessive apoptosis, because the gene can effectively and sustainably introduce anti-apoptotic factors into cells. However, DNA delivery poses the risk of random genomic integration, leading to overexpression of the delivered gene and cancer development. Messenger RNA (mRNA) can evade integration events ...
متن کاملCurrent Treatment Dilemmas in Neurological Disorders
All book chapters are Open Access distributed under the Creative Commons Attribution 3.0 license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. However, users who aim to disseminate and distribute copies of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Controlled Release
سال: 2015
ISSN: 0168-3659
DOI: 10.1016/j.jconrel.2015.01.017